Identification of SAA1 as a novel metastasis marker in ovarian cancer and development of a graphene-based detection platform for early assessment
- PMID: 37707574
- DOI: 10.1007/s00432-023-05296-8
Identification of SAA1 as a novel metastasis marker in ovarian cancer and development of a graphene-based detection platform for early assessment
Abstract
Background: Ovarian cancer (OC) is a prevalent gynecological malignancy with the highest mortality rate, which generally diagnosed at late stages due to the lack of effective early screening methods and the nonspecific symptoms. Hence, here we aim to identify new metastasis markers and develop a novel detection method with the characteristics of high sensitivity, rapid detection, high specificity, and low cost when compared with other conventional detection technologies.
Methods: Blood from OC patients with or without metastasis were collected and analyzed by 4D Label free LC - MS/MS. Surgically resect samples from OC patients were collected for Single cell RNA sequencing (sc-RNA seq). Short hairpin RNA (shRNA) was used to silence SAA1 expression in SKOV3 and ID8 to verify the relationship between endogenous SAA1 and tumor invasion or metastasis. The functional graphene chips prepared by covalent binding were used for SAA1 detection.
Results: In our study, we identified Serum Amyloid A1 (SAA1) as a hematological marker of OC metastasis by comprehensive analysis of proteins in plasma from OC patients with or without metastasis using 4D Label free LC - MS/MS and gene expression patterns from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. Further validation using tumor tissues and plasma from human OC and mouse OC model confirmed the correlation between SAA1 and tumor metastasis. Importantly, sc-RNA seq of human OC samples revealed that SAA1 was specifically expressed in tumor cells and upregulated in the metastasis group. The functional role of SAA1 in metastasis was demonstrated through experiments in vitro and in vivo. Based on these findings, we designed and investigated a graphene-based platform for SAA1 detection to predict the risk of metastasis of OC patients.
Conclusion: Our study suggests that SAA1 is a biomarker of OC metastasis, and we have developed a rapid and highly sensitive platform using graphene chips to detection of plasma SAA1 for the early assessment of metastasis in OC patients.
Keywords: Biomarker; Graphene chip; Metastasis; Ovarian cancer; Rapid detection; SAA1.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Cancer-associated adipocytes promote pancreatic cancer progression through SAA1 expression.Cancer Sci. 2020 Aug;111(8):2883-2894. doi: 10.1111/cas.14527. Epub 2020 Jul 6. Cancer Sci. 2020. PMID: 32535957 Free PMC article.
-
Activated macrophages promote invasion by early colorectal cancer via an interleukin 1β-serum amyloid A1 axis.Cancer Sci. 2021 Oct;112(10):4151-4165. doi: 10.1111/cas.15080. Epub 2021 Aug 12. Cancer Sci. 2021. PMID: 34293235 Free PMC article.
-
Arecoline induces epithelial-mesenchymal transformation and promotes metastasis of oral cancer by SAA1 expression.Cancer Sci. 2021 Jun;112(6):2173-2184. doi: 10.1111/cas.14866. Epub 2021 May 1. Cancer Sci. 2021. PMID: 33626219 Free PMC article.
-
Serum amyloid A1: Structure, function and gene polymorphism.Gene. 2016 May 25;583(1):48-57. doi: 10.1016/j.gene.2016.02.044. Epub 2016 Mar 3. Gene. 2016. PMID: 26945629 Free PMC article. Review.
-
Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis.EBioMedicine. 2022 May;79:104001. doi: 10.1016/j.ebiom.2022.104001. Epub 2022 Apr 16. EBioMedicine. 2022. PMID: 35439677 Free PMC article. Review.
Cited by
-
Ovarian cancer ascites proteomic profile reflects metabolic changes during disease progression.Biochem Biophys Rep. 2024 Jun 13;39:101755. doi: 10.1016/j.bbrep.2024.101755. eCollection 2024 Sep. Biochem Biophys Rep. 2024. PMID: 38974022 Free PMC article.
References
-
- Bast RC Jr, Lu Z, Han CY, Lu KH, Anderson KS, Drescher CW, Skates SJ (2020) Biomarkers and strategies for early detection of ovarian cancer. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 29:2504–2512 - DOI
-
- Cho WC, Yip TT, Yip C, Yip V, Thulasiraman V, Ngan RK, Yip TT, Lau WH, Au JS, Law SC et al (2004) Identification of serum amyloid a protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling. Clin Cancer 10:43–52 - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous